BensadounJ.C., DéglonN., TsengJ.L., RidetJ.L., ZurnA.D., AebischerP.2000. Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp. Neurol., 164:15–24.
2.
BoboR.H., LaskeD.W., AkbasakA., MorrisonP.F., DedrickR.L., OldfieldE.H.1994. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. U.S.A., 91:2076–2080.
EberlingJ.L., KellsA.P., PivirottoP., BeyerJ., BringasJ., FederoffH.J., ForsayethJ., BankiewiczK.S.2009. Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys. Hum. Gene Ther., 20:511–518.
5.
JohnstonL.C., EberlingJ., PivirottoP., HadaczekP., FederoffH.J., ForsayethJ., BankiewiczK.S.2009. Clinically relevant effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Hum. Gene Ther., 20:497–510.
6.
KirikD., RosenbladC., BjorklundA., MandelR.J.2000. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci., 20:4686–4700.
7.
KordowerJ.H., EmborgM.E., BlochJ., MaS.Y., ChuY., LeventhalL., McBrideJ., ChenE.Y., PalfiS., RoitbergB.Z., BrownW.D., HoldenJ.E., PyzalskiR., TaylorM.D., CarveyP., LingZ., TronoD., HantrayeP., DéglonN., AebischerP.2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290:767–773.
8.
McPheeS.W., JansonC.G., LiC., SamulskiR.J., CampA.S., FrancisJ., SheraD., LioutermannL., FeelyM., FreeseA., LeoneP.2006. Immune responses to AAV in a phase I study for Canavan disease. J. Gene Med., 8:577–588.
9.
NuttJ.G., BurchielK.J., ComellaC.L., JankovicJ., LangA.E., LawsE.R.Jr., LozanoA.M., PennR.D., SimpsonR.K.Jr., StacyM., WootenG.F.ICV GDNF Study Group. 2003. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology, 60:69–73.
10.
SauerH., RosenbladC., BjorklundA.1995. Glial cell line-derived neurotrophic factor but not transforming growth factor-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. U.S.A., 92:8935–8939.
